Fitness6 months ago
Desai Details Efforts Exploring Treatment Strategies in CLL Post–BTK Inhibitor Progression
In an interview with OncLive®, Sanjal Desai, MD, discussed the feasibility of venetoclax (Venclexta) rechallenge in patients with chronic lymphocytic leukemia (CLL) who progressed on prior...
